<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25622524</article-id><article-id pub-id-type="pmc">4318367</article-id><article-id pub-id-type="publisher-id">543</article-id><article-id pub-id-type="doi">10.1186/s13063-014-0543-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>A phase II trial for the efficacy of physiotherapy intervention for early-onset hip osteoarthritis: study protocol for a randomised controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kemp</surname><given-names>Joanne L</given-names></name><address><email>jkemp@federation.edu.au</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Moore</surname><given-names>Kate</given-names></name><address><email>katemoore@bodysystem.com.au</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Fransen</surname><given-names>Marlene</given-names></name><address><email>marlene.fransen@sydney.edu.au</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Russell</surname><given-names>Trevor G</given-names></name><address><email>t.russell1@uq.edu.au</email></address><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Crossley</surname><given-names>Kay M</given-names></name><address><email>k.crossley@uq.edu.au</email></address><xref ref-type="aff" rid="Aff4"/></contrib><aff id="Aff1"><label/>Australian Centre for Research into Injury in Sport and its Prevention (ACRISP), Federation University Australia, PO Box 663, Ballarat, 3350 VIC Australia </aff><aff id="Aff2"><label/>Bodysystem Physiotherapy, 38 Collins St, Hobart, 7000 TAS Australia </aff><aff id="Aff3"><label/>School of Physiotherapy, University of Sydney, 75 East St, Lidcombe, Sydney, 2141 NSW Australia </aff><aff id="Aff4"><label/>School of Health and Rehabilitation Sciences, University of Queensland, St Lucia, Brisbane, 4067 QLD Australia </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>16</volume><elocation-id>26</elocation-id><history><date date-type="received"><day>21</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; Kemp et al.; licensee BioMed Central. 2015</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Early-onset hip osteoarthritis is commonly seen in people undergoing hip arthroscopy and is associated with increased pain, reduced ability to participate in physical activity, reduced quality of life and reduced range of motion and muscle strength. Despite this, the efficacy of non-surgical interventions such as exercise therapies remains unknown. The primary aim is to establish the feasibility of a phase III randomised controlled trial investigating a targeted physiotherapy intervention for people with early-onset hip osteoarthritis. The secondary aims are to determine the size of treatment effects of a physiotherapy intervention, targeted to improve hip joint range and hip-related symptoms in early-onset hip osteoarthritis following hip arthroscopy, compared to a health-education control.</p></sec><sec><title>Methods</title><p>This protocol describes a randomised, assessor- and participant-blind, controlled clinical trial. We will include 20 participants who are (i) aged between 18 and 50&#x000a0;years; (ii) have undergone hip arthroscopy during the past six to 12&#x000a0;months; (iii) have early-onset hip osteoarthritis (defined as chondrolabral pathology) at the time of hip arthroscopy; and (iv) experience hip-related pain during activities. Primary outcome will be the feasibility of a phase III clinical trial. Secondary outcomes will be (i) perceived global change score; (ii) hip-related symptoms (measured using the Hip disability and Osteoarthritis Outcome Score (HOOS) pain subscale, activity subscale, and sport and recreation subscale); (iii) hip quality of life (measured using the HOOS quality of life subscale and International Hip Outcome tool; (iv) hip muscle strength and (v) hip range of motion. The physiotherapy intervention is semi-standardised, including joint and soft tissue mobilisation and stretching, hip and trunk muscle retraining and functional and activity-specific retraining and education. The control intervention encompasses individualised health education, with the same frequency and duration as the intervention. The trial primary end-point is the conclusion of the 12-week intervention, and follow-up measures will be collected at the 12-week post-baseline assessment.</p></sec><sec><title>Discussion</title><p>The findings of this study will provide guidance regarding the feasibility of a full-scale phase III randomised controlled trial, prior to its undertaking.</p></sec><sec><title>Trial registration</title><p>The trial protocol was registered with the Australian Clinical Trials Registry (number: <ext-link ext-link-type="uri" xlink:href="https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=365744">12614000426684</ext-link>) on 17 April 2014.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s13063-014-0543-7) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Osteoarthritis</kwd><kwd>Hip joint</kwd><kwd>Hip arthroscopy</kwd><kwd>Randomised controlled trial</kwd><kwd>Physiotherapy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Hip pathology is a common cause of hip pain [<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>], and is associated with considerable morbidity in people aged between 18 and 50&#x000a0;years [<xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref>]. In recent years, arthroscopic surgery has contributed to advancements in assessment and management of hip pain [<xref ref-type="bibr" rid="CR5">5</xref>]. Recently, the number of hip arthroscopic procedures performed in the United States [<xref ref-type="bibr" rid="CR6">6</xref>-<xref ref-type="bibr" rid="CR8">8</xref>], United Kingdom, Australia [<xref ref-type="bibr" rid="CR9">9</xref>] and Asia [<xref ref-type="bibr" rid="CR10">10</xref>] has increased dramatically. In Australia, Medicare data indicate that between 2010 and 2013 the number of people undergoing hip arthroscopy increased by over 50% [<xref ref-type="bibr" rid="CR9">9</xref>], while in the United States the rate of hip arthroscopic surgery increased six-fold between 2006 and 2010 [<xref ref-type="bibr" rid="CR7">7</xref>]. Despite good results at between five and 10&#x000a0;years post-arthroscopy years, those with osteoarthritis (OA) at arthroscopy consistently report less favourable outcomes when compared to those without OA [<xref ref-type="bibr" rid="CR11">11</xref>]. In addition, we recently observed that early-onset hip OA is associated with worse outcomes in people who have undergone hip arthroscopy [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p>Musculoskeletal conditions are second only to mental and behavioural disorders, as global contributors to years lived with disability [<xref ref-type="bibr" rid="CR13">13</xref>]. Due to its negative impact on individual functioning and health service expenditure, OA has been designated a National Health priority area [<xref ref-type="bibr" rid="CR14">14</xref>]. The hip joint is a common site for OA [<xref ref-type="bibr" rid="CR15">15</xref>], affecting approximately 12% of adults in the United Kingdom [<xref ref-type="bibr" rid="CR16">16</xref>] and the United States of America [<xref ref-type="bibr" rid="CR17">17</xref>]. As there is no cure for hip OA, the identification of non-surgical interventions that can reduce the progression of hip-related symptoms is important, as this will reduce disease burden [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p>We recently reported that chondrolabral pathology, a marker of early-onset hip OA, is common in people who undergo hip arthroscopy for hip pain, and is associated with worse pain, difficulty participating in physical activity and reduced quality-of-life compared to healthy controls [<xref ref-type="bibr" rid="CR19">19</xref>]. Moreover, it appears that early onset hip OA has a significant impact on young and middle-aged people being able to participate in physical activities without difficulty, which could ultimately lead to physical inactivity. Inactivity is associated with adverse health outcomes, which include type two diabetes, ischaemic heat disease, stroke, depression and certain cancers [<xref ref-type="bibr" rid="CR20">20</xref>]. If the progression of hip OA symptoms can be slowed in its early stages, people with hip OA may participate in greater levels of physical activity, limiting the public health burden of this disease [<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref>].</p><p>A full-scale phase III randomised controlled trial (RCT) is costly, and before undertaking such a study it is important to establish its feasibility [<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref>]. In Australia, hip arthroscopy is mostly conducted in the private sector and such patients may be unwilling to participate in an RCT. In addition, no RCT examining the effects of a physiotherapy intervention has been undertaken in this population, and adherence with the intervention is unknown. The treatment algorithm has not been tested within the constraints of a clinical trial and the adverse events are not known. Therefore, before committing to a full-scale RCT, the feasibility of such a study should be established by undertaking a phase II RCT [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p>The primary aim of this study is to establish the feasibility of a phase III RCT investigating a targeted physiotherapy intervention for people with early-onset hip OA. The secondary aims are to determine the size of treatment effects of a physiotherapy intervention, targeted to improve hip joint range and hip-related symptoms in early-onset hip OA following hip arthroscopy, compared to a health-education control.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods/Design</title><sec id="Sec3"><title>Experimental design</title><p>This protocol describes a randomised, assessor- and participant--blind, controlled clinical trial conforming to Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) [<xref ref-type="bibr" rid="CR25">25</xref>] guidelines. The trial protocol was registered with the Australian Clinical Trials Registry (ACTR number: 12614000426684) on 17 April 2014. Ethics approval was obtained through the University of Queensland Medical Research Ethics Committee (number: 2013001553).</p></sec><sec id="Sec4"><title>Participants</title><p>A total of 20 participants will be recruited through a single orthopedic surgeon (MGP) in Hobart, Australia, with extensive expertise in hip arthroscopy. This number of participants was chosen in order to determine the feasibility of recruitment into a larger scale phase III trial, as we estimate that 20 participants represents 30% of eligible patients from a single surgeon. In addition, 20 participants will allow for observation of sample variability and any possible adverse responses to the intervention. A project investigator (KM) will screen for eligibility based on history and examination.</p><sec id="Sec5"><title>Inclusion criteria</title><p>The inclusion criteria are as follows: (i) aged between 18 and 50&#x000a0;years; (ii) arthroscopy for intra-articular hip pathology during the past six to 12&#x000a0;months; (iii) evidence of early-onset hip OA (defined as chondrolabral pathology) at time of hip arthroscopy; (iv) hip-related pain during activities such as sitting, squatting, stair ambulation or twisting on the leg and (v) hip-related pain score of over 30 on a 100&#x000a0;mm visual analogue scale (VAS).</p></sec><sec id="Sec6"><title>Exclusion criteria</title><p>The exclusion criteria are as follows: (i) pain that is not confirmed by physical examination of the hip [<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref>]; (ii) concurrent symptoms of hip bursitis or tendinitis; (iii) surgical complications, including infection; (iv) planned lower limb surgery in the following 12&#x000a0;months (such as an arthroplasty); (v) physical inability to weight-bear fully or undertake testing procedures and (vi) inability to understand written and spoken English.</p></sec></sec><sec id="Sec7"><title>Procedure</title><p>Potential participants will be identified by the surgeon and invited to contact the project coordinator (JK). (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) The project coordinator will contact potential participants by phone if they do not respond to the initial invitation. Volunteers will be screened via telephone interview, followed by a clinical examination to confirm eligibility (KM). The randomisation schedule will be generated and maintained centrally by the University of Queensland, School of Health and Rehabilitation Sciences, and will be revealed to the project coordinator (JK) via telephone following the baseline assessment. The blinded researcher (KM) will obtain informed consent (Additional file <xref rid="MOESM1" ref-type="media">1</xref>) and will perform outcome assessments at baseline and three months. Participants will be instructed not to divulge their group allocation to the assessor. While physiotherapists cannot be blinded to group allocation, participants will be informed that they can receive one of two possible interventions. Thus, participants will remain blinded to treatment allocation. Participants will be asked to refrain from other treatments, but stable drug doses will be permitted. Physiotherapists will record per protocol treatment. Participants will record adherence with home exercises, adverse events and any co-interventions in a log book.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Flowchart of trial.</bold>
</p></caption><graphic xlink:href="13063_2014_543_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec8"><title>Outcome assessment</title><p>Outcomes will be assessed at baseline and at the trial primary end-point, which is at the conclusion of the 12-week intervention.</p></sec><sec id="Sec9"><title>Primary outcome measure: feasibility of a full-scale randomized controlled trial</title><p>Feasibility will be assessed by evaluating the willingness of participants to enrol; the number of eligible participants; the recruitment rate; adherence to the intervention, home exercises and log-book completion and the drop-out rate. Adverse events will be recorded.</p></sec><sec id="Sec10"><title>Secondary outcome measures: perceived global change score</title><p>Participants will rate their perceived change following treatment on a six-point ordinal scale (completely recovered, much improved, improved, no change, worse and much worse) [<xref ref-type="bibr" rid="CR28">28</xref>]. Measuring patient-perceived change using such scales has been shown to be clinically relevant and a stable concept for interpreting meaningful improvements from an individual perspective [<xref ref-type="bibr" rid="CR29">29</xref>].</p></sec><sec id="Sec11"><title>Secondary outcome measure: hip-related symptoms</title><p>The Hip disability and Osteoarthritis Outcome Score HOOS-pain [<xref ref-type="bibr" rid="CR30">30</xref>] will measure hip-related symptoms. The HOOS was evaluated in younger adults with OA [<xref ref-type="bibr" rid="CR30">30</xref>], and incorporates the Western Ontario MacMaster Universities Osteoarthritis Index (WOMAC) 3.0LK [<xref ref-type="bibr" rid="CR31">31</xref>]. The HOOS-pain subscale is equivalent to the WOMAC pain subscale. We have determined that the HOOS-pain subscale is reliable (intraclass correlation coefficient (ICC)&#x02009;=&#x02009;0.96; 95% confidence interval (CI): 0.93 to 0.98), with a low standard error of measurement (SEM) of four points out of 100, and is valid and responsive, with a minimal clinically important change (MCIC) of nine points [<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="Sec12"><title>Secondary outcome measures: hip-related quality of life</title><p>The International Hip Outcome tool (iHOT-33) and HOOS quality of life subscale (HOOS-Q) will measure hip-related quality of life. The iHOT-33 is a composite score that was developed for specific use in the hip arthroscopy population [<xref ref-type="bibr" rid="CR33">33</xref>]. We determined that it is reliable (ICC&#x02009;=&#x02009;0.93; 95% CI: 0.87 to 0.96), with a low SEM of six points out of 100, and is valid and responsive, with an MCIC of 10 points [<xref ref-type="bibr" rid="CR32">32</xref>]. The HOOS-Q [<xref ref-type="bibr" rid="CR30">30</xref>] is reliable (ICC&#x02009;=&#x02009;0.95; 95% CI: 0.84 to 0.97), with a low SEM of five points out of 100, and is valid and responsive, with an MCIC of 11 points [<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="Sec13"><title>Secondary outcome measures: other hip-related symptoms</title><p>Other hip-related symptoms will include the HOOS activity of daily living subscale (HOOS-A), the HOOS sport and recreation subscale (HOOS-Sp) and HOOS symptoms and stiffness subscale (HOOS-S). We determined these subscales were reliable (ICC: 0.93 to 0.96), with low SEMs of three to six points, and have MCICs ranging from six to 10 points [<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec14"><title>Secondary outcome measures: hip muscle strength and hip joint range</title><p>Hip abduction, extension and external rotation strength and hip flexion range will be measured using our previously published methods [<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref>], with high reliability (ICC: 0.87 to 0.95). Briefly, all strength tests will be performed with a Commander Power track II (J-Tech medical, Salt Lake City, Utah, USA) hand-held dynamometer. The tester will match the force generated by the participant performing an isometric muscle contraction (the &#x02018;make&#x02019; test) [<xref ref-type="bibr" rid="CR37">37</xref>] and the best of three tests will be recorded. Strength will be recorded as a torque measure, calculated by multiplying the force (measured in Newtons (N)) by the length of the moment arm (measured in metres (m)), and then data will be normalized for body weight (measured in kilograms ((kg) Nm/kg). Specifically, abductor strength will be measured in the supine position, with stabilisation of the contra-lateral thigh, and external rotation strength will be measured in the prone position, with stabilisation of the contra-lateral thigh [<xref ref-type="bibr" rid="CR35">35</xref>]. Hip flexion range will be measured in the supine position as an active range of motion measure, with stabilisation of the contra-lateral thigh. It will be measured using a Plurimeter inclinometer (Dr Rippstein, La Conversion, Switzerland) as the mean of three measures [<xref ref-type="bibr" rid="CR36">36</xref>].</p></sec><sec id="Sec15"><title>Other measures</title><sec id="Sec16"><title>Potential covariates for statistical analyses</title><p>The potential covariates for statistical analyses are body anthropometry: weight, height, body mass index and waist girth.</p></sec><sec id="Sec17"><title>Interventions</title><p>Each participant will be treated by experienced physiotherapists who will be trained and proficient in both interventions (physiotherapy and control). The physiotherapists will receive two training sessions prior to the commencement of the study. Monthly meetings between the treating physiotherapists and the project coordinator (JK) will occur throughout the trial to ensure that the physiotherapy intervention remains consistent. The intervention is a face-to-face physiotherapy intervention, which will be delivered in eight sessions over three months (once per week for four weeks, then once per fortnight for eight weeks). This semi-standardised type of intervention has been described previously in an RCT protocol for post-operative physiotherapy in patients with femoro-acetabular impingement [<xref ref-type="bibr" rid="CR38">38</xref>]. Participants will be asked to refrain from other physiotherapy interventions during the trial. All participants will be able to discuss concerns regarding their condition with the project coordinator (JK) throughout the trial if needed.</p><sec id="d30e611"><title>Physiotherapy intervention</title><p>Physiotherapy interventions are detailed in Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref> and Additional file <xref rid="MOESM2" ref-type="media">2</xref>. These consist of (i) manual hip joint and soft tissue mobilisation and stretching; (ii) hip muscle retraining; (iii) trunk muscle retraining; (iv) functional, proprioceptive and sports- or activity- specific retraining; (v) enhancing physical activity and (vi) education. The treatment will be tailored according to each patient&#x02019;s clinical presentation (such as strength, pain severity, sporting and functional needs), the presence of co-morbidities (such as back and other lower limb pain or pathology), and progressed based on response to exercise load, thus maximising the training effects. The physiotherapist will supervise exercises during each visit. A home exercise program will be performed independently at home four times per week. An exercise manual will be made accessible to each participant.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Manual therapy techniques: a semi-standardised approach</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th colspan="5">
<bold>Manual therapy techniques</bold>
</th></tr><tr valign="top"><th>
<bold>Technique</bold>
</th><th>
<bold>Aim</bold>
</th><th>
<bold>Description</bold>
</th><th>
<bold>Dosage</bold>
</th><th>
<bold>Timeframe</bold>
</th></tr></thead><tbody><tr valign="top"><td rowspan="2">Soft tissue massage and trigger point release of iliopsoas, adductor group, gluteus minimus, gluteus medius, piriformis and tensor fascia latae</td><td rowspan="2">Address soft tissue restrictions with the aim of reducing pain and increasing hip joint range of movement</td><td>Sustained digital pressure to each trigger point, with the muscle positioned on stretch</td><td>30 - 60&#x000a0;seconds digital pressure per trigger point</td><td rowspan="2">Session 1 - 8</td></tr><tr valign="top"><td>Massage longitudinally along the muscle belly</td><td>2 - 5&#x000a0;minutes of massage per muscle</td></tr><tr valign="top"><td>Mobilisation of lumbar spine</td><td>To improve lumbar spine mobility and restore normal lumbo-pelvic movement</td><td>Unilateral postero-anterior accessory glides, Grade III or IV</td><td>3 - 5 sets of 30 - 60&#x000a0;seconds</td><td>Session 1 - 8</td></tr><tr valign="top"><td rowspan="2">Correction of sacro-iliac joint asymmetries</td><td rowspan="2">To optimise the position of the ilium and therefore the orientation of the acetabulum</td><td>Massage to iliopsoas</td><td rowspan="2">2 - 5&#x000a0;minutes of massage</td><td rowspan="2">Session 1 - 8</td></tr><tr valign="top"><td>Mobilisation of sacrum</td></tr><tr valign="top"><td>Manual traction if ligamentum teres is intact or ligated and patient is &#x0003e;3&#x000a0;months post-labral repair</td><td>Increase hip flexion and/or IR/ER range of motion</td><td>Seatbelt around patient's proximal femur and therapist's hips. Gentle inferior and/or lateral traction force applied. May include patient actively moving hip into flexion as traction is applied</td><td>3 sets of 10&#x000a0;seconds. If tolerated, increase by 1 set per treatment session to a maximum of 6 sets in total</td><td>Session 1 - 8</td></tr></tbody></table><table-wrap-foot><p>Legend: IR&#x02009;=&#x02009;internal rotation; ER&#x02009;=&#x02009;external rotation.</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Home exercise program for hip muscle retraining, trunk muscle retraining, functional and activity specific retraining and stretching: a semi-standardised approach</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th colspan="4">
<bold>Home exercise program</bold>
</th></tr><tr valign="top"><th>
<bold>Exercise</bold>
</th><th>
<bold>Aim</bold>
</th><th>
<bold>Description</bold>
</th><th>
<bold>Timeframe</bold>
</th></tr></thead><tbody><tr valign="top"><td>Deep hip rotator strengthening</td><td>Optimize hip neuromuscular control and improve dynamic stability of hip</td><td>See Additional file <xref rid="MOESM2" ref-type="media">2</xref>
</td><td>Session 1 - 4</td></tr><tr valign="top"><td>Hip extensor muscle strengthening</td><td>Optimize hip neuromuscular control and improve dynamic stability of hip</td><td>See Additional file <xref rid="MOESM2" ref-type="media">2</xref>
</td><td>Session 1 - 6</td></tr><tr valign="top"><td>Hip abductor muscle strengthening</td><td>Optimize hip neuromuscular control and improve dynamic stability of hip</td><td>See Additional file <xref rid="MOESM2" ref-type="media">2</xref>
</td><td>Session 2 - 8</td></tr><tr valign="top"><td>Functional strengthening</td><td>Improve gluteal and lower limb strength. Practice movement patterns required for optimal daily function</td><td>See Additional file <xref rid="MOESM2" ref-type="media">2</xref>
</td><td>Session 3 - 8</td></tr><tr valign="top"><td>Balance exercises</td><td>Improve proprioception and dynamic stability of hip and pelvis</td><td>See Additional file <xref rid="MOESM2" ref-type="media">2</xref>
</td><td>Session 2 - 8</td></tr><tr valign="top"><td>Anterior hip stretch</td><td>Assist in regaining full hip extension range of movement</td><td>See Additional file <xref rid="MOESM2" ref-type="media">2</xref>
</td><td>Session 2 - 8</td></tr></tbody></table></table-wrap></p><p>Specific aspects of the treatment include:<list list-type="order"><list-item><p>Manual hip joint and soft tissue mobilisation and stretching to provide optimal joint range and facilitate control of movement patterns. Within each treatment session, the therapist will measure range of motion (with an inclinometer), and monitor the immediate effects of treatment modalities.</p></list-item><list-item><p>Hip muscle retraining, including exercise to improve hip abduction, extension and external rotator coordination and strength. In order to accommodate a heterogeneous cohort, the hip muscle retraining may be performed statically and/or dynamically in various functional activities (for example, step up and down, squat and/or sit to stand). Resistance will be progressed based on individual responses, and is detailed in Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>.</p></list-item><list-item><p>Trunk muscle retraining to improve strength, endurance and control of the trunk muscles. The exercise selection and progression will follow similar principles to the hip muscle retraining.</p></list-item><list-item><p>Functional, proprioceptive and sports-specific retraining. The exercise selection and progression will follow similar principles to the hip and trunk muscle retraining. For example, a person aiming to return to football may perform single leg activities with direction change and pain-free, graduated return to kicking, whilst maintaining good movement control.</p></list-item></list><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Examples of hip exercise progression from non-weight bearing to functional tasks.</bold>
</p></caption><graphic xlink:href="13063_2014_543_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="d30e946"><title>Control</title><p>In order to control for the psychosocial contact inherent with the physiotherapy treatment, the control treatment will encompass individualised health education sessions covering topics such as exercise, diet, weight loss and appropriate stretching, in a similar fashion to previously published clinical trials looking at physiotherapy management in older people with advanced hip OA [<xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref>]. The information sheets have been modified to be appropriate for this younger age group. The control sessions will be provided with the same frequency and duration as the physiotherapy sessions.</p></sec><sec id="d30e957"><title>Data management, monitoring and statistical analyses</title><p>Treatment efficacy will be evaluated by comparing change on primary outcome measures between groups. Baseline characteristics of participating patients of the two groups will be evaluated for their influence on outcomes and included as covariates in statistical analyses if required. Outcomes of interest will be analysed on an intention-to-treat basis for all participants. SPSS software (Version 21, SPSS Inc, Chicago, IL, USA) will be used for all analyses, and significance will be set at <italic>P</italic> &#x0003c;0.05. Data monitoring will be conducted by an independent investigator (KC), and data will be stored in a locked cabinet and password-secured server. Adverse events will be recorded by the treating physiotherapists who will inform the project coordinator (JK). Trial results will be made available to participants and will be published in a peer-reviewed journal.</p></sec></sec></sec><sec id="Sec18"><title>Consent</title><p>Written informed consent was obtained from the patients for publication of this manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p></sec></sec><sec id="Sec19" sec-type="discussion"><title>Discussion</title><p>This study provides detail of the protocol for a phase II RCT investigating the efficacy of a physiotherapy intervention for early-onset hip OA [<xref ref-type="bibr" rid="CR24">24</xref>]. This phase II study will identify the willingness of patients to enter a phase III RCT, adherence to the interventions and possible drop-out rates. In addition, this study will provide information regarding the treatment effects sizes of the semi-individualised physiotherapy intervention described, and assist in power calculations which will inform future larger scale RCTs.</p><p>The physiotherapy intervention described herein is semi-individualised, wherein a standardised program is tailored to the individual patient&#x02019;s needs, based on assessment and reassessment undertaken at each physiotherapy session. Impairments in hip range of motion and hip muscle strength have been identified previously in people with chondropathy of the hip [<xref ref-type="bibr" rid="CR41">41</xref>]. Therefore we have included therapeutic interventions targeted to address these impairments in the physiotherapy intervention.</p><p>The control intervention is an alternative physiotherapy intervention, focussing on education and guidance, rather than a &#x02018;wait and see&#x02019; control group. This will control for both the attention and advice provided by physiotherapists during individual treatment sessions and may facilitate recruitment, since all patients will receive an active intervention regardless of treatment allocation.</p><p>The findings of this study will provide guidance regarding the feasibility of a full-scale phase III RCT, prior to its undertaking [<xref ref-type="bibr" rid="CR24">24</xref>]. It will also provide pilot data on the efficacy of the physiotherapy intervention described herein.</p></sec><sec id="Sec20"><title>Trial status</title><p>This trial is ongoing. At the time of submission of this protocol, 17 patients had been recruited into the study over a four-month recruitment period, and 16 patients had completed the follow-up period. There have been no reported adverse events, drop-outs or patients lost to follow-up to date.</p></sec></body><back><app-group><app id="App1"><sec id="Sec21"><title>Additional files</title><p><media position="anchor" xlink:href="13063_2014_543_MOESM1_ESM.docx" id="MOESM1"><label>Additional file 1:</label><caption><p>
<bold>A randomized clinical trial of physiotherapy intervention for early-onset hip osteoarthritis.</bold>
</p></caption></media><media position="anchor" xlink:href="13063_2014_543_MOESM2_ESM.docx" id="MOESM2"><label>Additional file 2:</label><caption><p>
<bold>Specific examples of exercises included in home exercise program.</bold>
</p></caption></media></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-list><def-item><term>HOOS</term><def><p>Hip disability and osteoarthritis outcome score</p></def></def-item><def-item><term>ICC</term><def><p>Intraclass correlation coefficient</p></def></def-item><def-item><term>iHOT</term><def><p>International Hip Outcome tool</p></def></def-item><def-item><term>MCIC</term><def><p>Minimal clinically important change</p></def></def-item><def-item><term>N</term><def><p>Newton</p></def></def-item><def-item><term>OA</term><def><p>Osteoarthritis</p></def></def-item><def-item><term>RCT</term><def><p>Randomised controlled trial</p></def></def-item><def-item><term>SEM</term><def><p>Standard error of measurement</p></def></def-item><def-item><term>VAS</term><def><p>Visual analogue scale</p></def></def-item><def-item><term>WOMAC</term><def><p>Western Ontario MacMaster Universities Osteoarthritis Index</p></def></def-item></def-list></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>JK contributed to conception and design of the trial, the acquisition of data, and will contribute to the analysis and interpretation of data; has been involved in drafting the manuscript and revising it critically for important intellectual content; and has given final approval of the version to be published. KM contributed to conception and design of the trial, the acquisition of data, and will contribute to the analysis and interpretation of data; has been involved in revising the manuscript critically for important intellectual content; and has given final approval of the version to be published. MF contributed to conception and design of the trial and will contribute to the interpretation of data; has been involved in revising the manuscript critically for important intellectual content; and has given final approval of the version to be published. TR contributed to conception and design of the trial and will contribute to the interpretation of data; has been involved in revising the manuscript critically for important intellectual content; and has given final approval of the version to be published. KC contributed to conception and design of the trial, the acquisition of data, and will contribute to the analysis and interpretation of data; has been involved in drafting the manuscript and revising it critically for important intellectual content; and has given final approval of the version to be published.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to acknowledge Mr Michael Pritchard for assistance with participant recruitment.</p><p>This trial was funded by the Australian Physiotherapy Research Foundation Beryl Haynes Memorial Grant (grant number T13-BH007), and Bodysystem Pty Ltd. Funders will not play a role in the publication or dissemination of study findings.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganz</surname><given-names>R</given-names></name><name><surname>Parvizi</surname><given-names>J</given-names></name><name><surname>Beck</surname><given-names>M</given-names></name><name><surname>Leunig</surname><given-names>M</given-names></name><name><surname>N&#x000f6;tzli</surname><given-names>H</given-names></name><name><surname>Siebenrock</surname><given-names>KA</given-names></name></person-group><article-title>Femoroacetabular impingement: a cause for osteoarthritis of the Hip</article-title><source>Clin Orthop Relat Res.</source><year>2003</year><volume>417</volume><fpage>112</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">14646708</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvizi</surname><given-names>J</given-names></name><name><surname>Bican</surname><given-names>O</given-names></name><name><surname>Bender</surname><given-names>B</given-names></name><name><surname>Mortazavi</surname><given-names>SMJ</given-names></name><name><surname>Purtill</surname><given-names>JJ</given-names></name><name><surname>Erickson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Arthroscopy for labral tears in patients with developmental dysplasia of the hip: a cautionary note</article-title><source>J Arthroplasty.</source><year>2009</year><volume>24</volume><issue>Suppl 6</issue><fpage>110</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2009.05.021</pub-id><pub-id pub-id-type="pmid">19596542</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnett</surname><given-names>RSJ</given-names></name><name><surname>Della Rocca</surname><given-names>GJ</given-names></name><name><surname>Prather</surname><given-names>H</given-names></name><name><surname>Curry</surname><given-names>M</given-names></name><name><surname>Maloney</surname><given-names>WJ</given-names></name><name><surname>Clohisy</surname><given-names>JC</given-names></name></person-group><article-title>Clinical presentation of patients with tears of the acetabular labrum</article-title><source>J Bone Joint Surg Am</source><year>2006</year><volume>88</volume><issue>7</issue><fpage>1448</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.2106/JBJS.D.02806</pub-id><pub-id pub-id-type="pmid">16818969</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippon</surname><given-names>MJ</given-names></name><name><surname>Weiss</surname><given-names>DR</given-names></name><name><surname>Kuppersmith</surname><given-names>DA</given-names></name><name><surname>Briggs</surname><given-names>KK</given-names></name><name><surname>Hay</surname><given-names>CJ</given-names></name></person-group><article-title>Arthroscopic labral repair and treatment of femoroacetabular impingement in professional hockey players</article-title><source>Am J Sports Med</source><year>2010</year><volume>38</volume><issue>1</issue><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1177/0363546509346393</pub-id><pub-id pub-id-type="pmid">19966097</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradshaw</surname><given-names>CJ</given-names></name><name><surname>Bundy</surname><given-names>M</given-names></name><name><surname>Falvey</surname><given-names>E</given-names></name></person-group><article-title>The diagnosis of longstanding groin pain: a prospective clinical cohort study</article-title><source>Br J Sports Med</source><year>2008</year><volume>42</volume><issue>10</issue><fpage>551</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1136/bjsm.2007.039685</pub-id><pub-id pub-id-type="pmid">18424484</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clohisy</surname><given-names>JC</given-names></name><name><surname>Baca</surname><given-names>G</given-names></name><name><surname>Beaul&#x000e9;</surname><given-names>PE</given-names></name><name><surname>Kim</surname><given-names>Y-J</given-names></name><name><surname>Larson</surname><given-names>CM</given-names></name><name><surname>Millis</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Descriptive epidemiology of femoroacetabular impingement: a North American cohort of patients undergoing surgery</article-title><source>Am J Sports Med.</source><year>2013</year><volume>41</volume><fpage>1348</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1177/0363546513488861</pub-id><pub-id pub-id-type="pmid">23669751</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozic</surname><given-names>KJ</given-names></name><name><surname>Chan</surname><given-names>V</given-names></name><name><surname>Valone</surname><given-names>FH</given-names><suffix>3rd</suffix></name><name><surname>Feeley</surname><given-names>BT</given-names></name><name><surname>Vail</surname><given-names>TP</given-names></name></person-group><article-title>Trends in hip arthroscopy utilization in the United States</article-title><source>J Arthroplasty.</source><year>2013</year><volume>28</volume><issue>Suppl 8</issue><fpage>140</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2013.02.039</pub-id><pub-id pub-id-type="pmid">23916639</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>SR</given-names></name><name><surname>Ngo</surname><given-names>SS</given-names></name><name><surname>Hobson</surname><given-names>T</given-names></name><name><surname>Nguyen</surname><given-names>S</given-names></name><name><surname>Alluri</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Trends and demographics in hip arthroscopy in the United States</article-title><source>Arthroscopy.</source><year>2013</year><volume>29</volume><fpage>661</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.arthro.2012.11.005</pub-id><pub-id pub-id-type="pmid">23375668</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Medicare Australia. Medicare Item 49366 processed from July 2007 to June 2010. 2014. <ext-link ext-link-type="uri" xlink:href="http://www.medicareaustralia.gov.au/cgi-bin/broker.exe?_PROGRAM=sas.mbs_item_age_gender_report.sas&#x00026;_SERVICE=default&#x00026;_DEBUG=0&#x00026;VAR=services&#x00026;STAT=count&#x00026;PTYPE=finyear&#x00026;START_DT=200707&#x00026;END_DT=201006&#x00026;RPT_FMT=by+state&#x00026;GROUP=49366">http://www.medicareaustralia.gov.au/cgi-bin/broker.exe?_PROGRAM=sas.mbs_item_age_gender_report.sas&#x00026;_SERVICE=default&#x00026;_DEBUG=0&#x00026;VAR=services&#x00026;STAT=count&#x00026;PTYPE=finyear&#x00026;START_DT=200707&#x00026;END_DT=201006&#x00026;RPT_FMT=by+state&#x00026;GROUP=49366</ext-link>. Accessed 13 Jan 2014.</mixed-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Ha</surname><given-names>YC</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Koo</surname><given-names>KH</given-names></name></person-group><article-title>National trends of hip arthroscopy in Korea</article-title><source>J Korean Med Sci</source><year>2014</year><volume>29</volume><issue>2</issue><fpage>277</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.3346/jkms.2014.29.2.277</pub-id><pub-id pub-id-type="pmid">24550658</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>MacDonald</surname><given-names>D</given-names></name><name><surname>Collins</surname><given-names>NJ</given-names></name><name><surname>Hatton</surname><given-names>AL</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name></person-group><article-title>Hip arthroscopy for hip osteoarthritis: a systematic review of outcomes and factors influencing outcomes</article-title><source>Osteoarthritis Cartilage.</source><year>2014</year><volume>22 Suppl</volume><fpage>S182</fpage><pub-id pub-id-type="doi">10.1016/j.joca.2014.02.344</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>Collins</surname><given-names>NJ</given-names></name><name><surname>Makdissi</surname><given-names>M</given-names></name><name><surname>Schache</surname><given-names>AG</given-names></name><name><surname>Machotka</surname><given-names>Z</given-names></name><name><surname>Crossley</surname><given-names>K</given-names></name></person-group><article-title>Hip arthroscopy for intra-articular pathology: a systematic review of outcomes with and without femoral osteoplasty</article-title><source>Br J Sports Med</source><year>2012</year><volume>46</volume><issue>9</issue><fpage>632</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2011-090428</pub-id><pub-id pub-id-type="pmid">22194221</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vos</surname><given-names>T</given-names></name><name><surname>Flaxman</surname><given-names>AD</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name><name><surname>Lozano</surname><given-names>R</given-names></name><name><surname>Michaud</surname><given-names>C</given-names></name><name><surname>Ezzati</surname><given-names>M</given-names></name><etal/></person-group><article-title>Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990&#x02013;2010: a systematic analysis for the Global Burden of Disease Study 2010</article-title><source>Lancet</source><year>2012</year><volume>380</volume><issue>9859</issue><fpage>2163</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)61729-2</pub-id><pub-id pub-id-type="pmid">23245607</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>March</surname><given-names>L</given-names></name><name><surname>Bagga</surname><given-names>H</given-names></name></person-group><article-title>Epidemiology of osteoarthritis in Australia</article-title><source>Med J Aust.</source><year>2004</year><volume>180</volume><issue>Suppl 5</issue><fpage>S6</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">14984356</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busija</surname><given-names>L</given-names></name><name><surname>Bridgett</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>SRM</given-names></name><name><surname>Osborne</surname><given-names>RH</given-names></name><name><surname>Buchbinder</surname><given-names>R</given-names></name><name><surname>March</surname><given-names>L</given-names></name><etal/></person-group><article-title>Osteoarthritis</article-title><source>Best Pract Re: Clin Rheumatol</source><year>2010</year><volume>24</volume><issue>6</issue><fpage>757</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.berh.2010.11.001</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odding</surname><given-names>E</given-names></name></person-group><article-title>Associations of radiographical osteoarthritis of the hip and knee with locomotor disability in the Rotterdam Study</article-title><source>Ann Rheum Dis</source><year>1998</year><volume>57</volume><issue>4</issue><fpage>203</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1136/ard.57.4.203</pub-id><pub-id pub-id-type="pmid">9709175</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>RC</given-names></name><name><surname>Helmick</surname><given-names>CG</given-names></name><name><surname>Arnett</surname><given-names>FC</given-names></name><name><surname>Deyo</surname><given-names>RA</given-names></name><name><surname>Felson</surname><given-names>DT</given-names></name><name><surname>Giannini</surname><given-names>EH</given-names></name><etal/></person-group><article-title>Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States</article-title><source>Arthritis Rheum.</source><year>1998</year><volume>41</volume><fpage>778</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1002/1529-0131(199805)41:5&#x0003c;778::AID-ART4&#x0003e;3.0.CO;2-V</pub-id><pub-id pub-id-type="pmid">9588729</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Moskowitz</surname><given-names>RW</given-names></name><name><surname>Nuki</surname><given-names>G</given-names></name><name><surname>Abramson</surname><given-names>S</given-names></name><name><surname>Altman</surname><given-names>RD</given-names></name><name><surname>Arden</surname><given-names>N</given-names></name><etal/></person-group><article-title>OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines</article-title><source>Osteoarthritis Cartilage</source><year>2008</year><volume>16</volume><issue>2</issue><fpage>137</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2007.12.013</pub-id><pub-id pub-id-type="pmid">18279766</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>Makdissi</surname><given-names>M</given-names></name><name><surname>Pritchard</surname><given-names>MG</given-names></name><name><surname>Schache</surname><given-names>AG</given-names></name><name><surname>Pollard</surname><given-names>TCB</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name></person-group><article-title>Chondropathy of the hip at arthroscopy: prevalence and relationship to labral pathology, femoro-acetabular impingement and patient-reported outcomes</article-title><source>Br J Sports Med.</source><year>2014</year><volume>48</volume><fpage>1102</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2013-093312</pub-id><pub-id pub-id-type="pmid">24659505</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pratt</surname><given-names>M</given-names></name><name><surname>Norris</surname><given-names>J</given-names></name><name><surname>Lobelo</surname><given-names>F</given-names></name><name><surname>Roux</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name></person-group><article-title>The cost of physical inactivity: moving into the 21st century</article-title><source>Br J Sports Med</source><year>2014</year><volume>48</volume><issue>3</issue><fpage>171</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2012-091810</pub-id><pub-id pub-id-type="pmid">23134760</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>OP</given-names></name><name><surname>Khan</surname><given-names>KM</given-names></name><name><surname>Hankey</surname><given-names>GJ</given-names></name><name><surname>Yeap</surname><given-names>BB</given-names></name><name><surname>Golledge</surname><given-names>J</given-names></name><name><surname>Flicker</surname><given-names>L</given-names></name></person-group><article-title>150&#x02005;minutes of vigorous physical activity per week predicts survival and successful ageing: a population-based 11-year longitudinal study of 12&#x02005;201 older Australian men</article-title><source>Br J Sports Med</source><year>2014</year><volume>48</volume><issue>3</issue><fpage>220</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2013-092814</pub-id><pub-id pub-id-type="pmid">24002240</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekblom-Bak</surname><given-names>E</given-names></name><name><surname>Ekblom</surname><given-names>B</given-names></name><name><surname>Vikstr&#x000f6;m</surname><given-names>M</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>Hell&#x000e9;nius</surname><given-names>M-L</given-names></name></person-group><article-title>The importance of non-exercise physical activity for cardiovascular health and longevity</article-title><source>Br J Sports Med</source><year>2014</year><volume>48</volume><issue>3</issue><fpage>233</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2012-092038</pub-id><pub-id pub-id-type="pmid">24167194</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>AJR</given-names></name><name><surname>Thomas</surname><given-names>GER</given-names></name><name><surname>Pollard</surname><given-names>TCB</given-names></name><name><surname>Rombach</surname><given-names>I</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Arden</surname><given-names>N</given-names></name><etal/></person-group><article-title>The feasibility of performing a randomised controlled trial for femoroacetabular impingement surgery</article-title><source>Bone Joint Res</source><year>2013</year><volume>2</volume><issue>2</issue><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1302/2046-3758.22.2000137</pub-id><pub-id pub-id-type="pmid">23610700</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">National Health and Medical Research Council clinical trials centre. Clinical trial designs and sample size. Sydney: University of Sydney; 22 September 2009. Report No.</mixed-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>AW</given-names></name><name><surname>Tetzlaff</surname><given-names>JM</given-names></name><name><surname>Gotzsche</surname><given-names>P</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Mann</surname><given-names>H</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><etal/></person-group><article-title>SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials</article-title><source>BMJ.</source><year>2013</year><volume>346</volume><fpage>e7586</fpage><pub-id pub-id-type="doi">10.1136/bmj.e7586</pub-id><pub-id pub-id-type="pmid">23303884</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name><name><surname>Schache</surname><given-names>AG</given-names></name><name><surname>Pritchard</surname><given-names>M</given-names></name><etal/></person-group><person-group person-group-type="editor"><name><surname>Brukner</surname><given-names>PD</given-names></name><name><surname>Bahr</surname><given-names>R</given-names></name><name><surname>Blair</surname><given-names>S</given-names></name><name><surname>Cook</surname><given-names>JL</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name><name><surname>McConnell</surname><given-names>J</given-names></name><etal/></person-group><article-title>Hip-related pain</article-title><source>Clinical sports medicine</source><year>2012</year><edition>4</edition><publisher-loc>Sydney</publisher-loc><publisher-name>McGraw-Hill</publisher-name><fpage>510</fpage><lpage>44</lpage></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>K</given-names></name></person-group><article-title>The development of hip osteoarthritis: implications for conservative management</article-title><source>Man Ther</source><year>1999</year><volume>4</volume><issue>3</issue><fpage>127</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1054/math.1999.0191</pub-id><pub-id pub-id-type="pmid">10513442</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisset</surname><given-names>L</given-names></name><name><surname>Beller</surname><given-names>E</given-names></name><name><surname>Jull</surname><given-names>G</given-names></name><name><surname>Brooks</surname><given-names>P</given-names></name><name><surname>Darnell</surname><given-names>R</given-names></name><name><surname>Vicenzino</surname><given-names>B</given-names></name></person-group><article-title>Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial</article-title><source>BMJ</source><year>2006</year><volume>333</volume><issue>7575</issue><fpage>939</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1136/bmj.38961.584653.AE</pub-id><pub-id pub-id-type="pmid">17012266</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ten Klooster</surname><given-names>PM</given-names></name><name><surname>Drossaers-Bakker</surname><given-names>KW</given-names></name><name><surname>Taal</surname><given-names>E</given-names></name><name><surname>van de Laar</surname><given-names>MA</given-names></name></person-group><article-title>Patient-perceived satisfactory improvement (PPSI): interpreting meaningful change in pain from the patient's perspective</article-title><source>Pain</source><year>2006</year><volume>121</volume><issue>1&#x02013;2</issue><fpage>151</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2005.12.021</pub-id><pub-id pub-id-type="pmid">16472915</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsdotter</surname><given-names>A</given-names></name><name><surname>Bremander</surname><given-names>A</given-names></name></person-group><article-title>Measures of hip function and symptoms</article-title><source>Arthritis Care Res.</source><year>2011</year><volume>63</volume><issue>Suppl 11</issue><fpage>S200</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/acr.20549</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellamy</surname><given-names>N</given-names></name><name><surname>Buchanon</surname><given-names>WW</given-names></name><name><surname>Goldsmith</surname><given-names>CH</given-names></name><name><surname>Campbell</surname><given-names>J</given-names></name><name><surname>Stitt</surname><given-names>L</given-names></name></person-group><article-title>Validation study of WOMAC: a health status instrument for measuring clinically-important patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis</article-title><source>J Rheumatol.</source><year>1988</year><volume>15</volume><fpage>1833</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">3068365</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>Collins</surname><given-names>NJ</given-names></name><name><surname>Roos</surname><given-names>EM</given-names></name><name><surname>Pritchard</surname><given-names>MG</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name></person-group><source>Patient-reported outcome scores for hip arthroscopy demonstrate adequate psychometric properties</source><year>2013</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Osteoarthritis Research Society International</publisher-name></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohtadi</surname><given-names>NGH</given-names></name><name><surname>Griffin</surname><given-names>DR</given-names></name><name><surname>Pedersen</surname><given-names>ME</given-names></name><name><surname>Chan</surname><given-names>D</given-names></name><name><surname>Safran</surname><given-names>MR</given-names></name><name><surname>Parsons</surname><given-names>N</given-names></name><etal/></person-group><article-title>The development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33)</article-title><source>Arthroscopy</source><year>2012</year><volume>28</volume><issue>5</issue><fpage>595</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/j.arthro.2012.03.013</pub-id><pub-id pub-id-type="pmid">22542433</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>Collins</surname><given-names>NJ</given-names></name><name><surname>Roos</surname><given-names>EM</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name></person-group><article-title>Psychometric properties of patient-reported outcome measures for hip arthroscopy</article-title><source>Am J Sports Med.</source><year>2013</year><volume>41</volume><fpage>2065</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1177/0363546513494173</pub-id><pub-id pub-id-type="pmid">23835268</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>Schache</surname><given-names>AG</given-names></name><name><surname>Makdissi</surname><given-names>M</given-names></name><name><surname>Sims</surname><given-names>K</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name></person-group><article-title>Greater understanding of normal hip physical function may guide clinicians in providing targeted rehabilitation programmes</article-title><source>J Sci Med Sport.</source><year>2013</year><volume>16</volume><fpage>292</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.jsams.2012.11.887</pub-id><pub-id pub-id-type="pmid">23266242</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatton</surname><given-names>AL</given-names></name><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>Brauer</surname><given-names>SG</given-names></name><name><surname>Clark</surname><given-names>RA</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name></person-group><article-title>Dynamic single-leg balance performance is impaired in individuals with hip chondropathy</article-title><source>Arthritis Care Res</source><year>2014</year><volume>66</volume><issue>5</issue><fpage>709</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/acr.22193</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorborg</surname><given-names>K</given-names></name><name><surname>Serner</surname><given-names>A</given-names></name><name><surname>Petersen</surname><given-names>J</given-names></name><name><surname>Madsen</surname><given-names>TM</given-names></name><name><surname>Magnusson</surname><given-names>P</given-names></name><name><surname>H&#x000f6;lmich</surname><given-names>P</given-names></name></person-group><article-title>Hip adduction and abduction strength profiles in elite soccer players: implications for clinical evaluation of hip adductor muscle recovery after injury</article-title><source>Am J Sports Med.</source><year>2011</year><volume>39</volume><fpage>121</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1177/0363546510378081</pub-id><pub-id pub-id-type="pmid">20929931</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennell</surname><given-names>K</given-names></name><name><surname>O'Donnell</surname><given-names>J</given-names></name><name><surname>Takla</surname><given-names>A</given-names></name><name><surname>Spiers</surname><given-names>L</given-names></name><name><surname>Hunter</surname><given-names>D</given-names></name><name><surname>Staples</surname><given-names>M</given-names></name><etal/></person-group><article-title>Efficacy of a physiotherapy rehabilitation program for individuals undergoing arthroscopic management of femoroacetabular impingement &#x02013; the FAIR trial: a randomised controlled trial protocol</article-title><source>BMC Musculoskelet Disord.</source><year>2014</year><volume>15</volume><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/1471-2474-15-58</pub-id><pub-id pub-id-type="pmid">24571824</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulsen</surname><given-names>T</given-names></name><name><surname>Christensen</surname><given-names>H</given-names></name><name><surname>Roos</surname><given-names>EM</given-names></name><name><surname>Vach</surname><given-names>W</given-names></name><name><surname>Overgaard</surname><given-names>S</given-names></name><name><surname>Hartvigsen</surname><given-names>J</given-names></name></person-group><article-title>Non-surgical treatment of hip osteoarthritis. hip school, with or without the addition of manual therapy, in comparison to a minimal control intervention: protocol for a three-armed randomized clinical trial</article-title><source>BMC Musculoskeletal Disorders.</source><year>2011</year><volume>12</volume><fpage>88</fpage><pub-id pub-id-type="doi">10.1186/1471-2474-12-88</pub-id><pub-id pub-id-type="pmid">21542914</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juhakoski</surname><given-names>R</given-names></name><name><surname>Malmivaara</surname><given-names>A</given-names></name><name><surname>Kiviniemi</surname><given-names>V</given-names></name><name><surname>Anttonen</surname><given-names>T</given-names></name><name><surname>Arokoski</surname><given-names>JP</given-names></name></person-group><article-title>A pragmatic randomized controlled study of the effectiveness and cost consequences of exercise therapy in hip osteoarthritis</article-title><source>Clin Rehabil.</source><year>2011</year><volume>25</volume><fpage>370</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1177/0269215510388313</pub-id><pub-id pub-id-type="pmid">21078702</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>JL</given-names></name><name><surname>Schache</surname><given-names>AG</given-names></name><name><surname>Makdissi</surname><given-names>M</given-names></name><name><surname>Pritchard</surname><given-names>MG</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name></person-group><article-title>People with chondropathy have greater physical impairments than those without following hip arthroscopy</article-title><source>Osteoarthritis Cartilage.</source><year>2013</year><volume>21 Suppl</volume><fpage>S274</fpage><pub-id pub-id-type="doi">10.1016/j.joca.2013.02.574</pub-id></element-citation></ref></ref-list></back></article>